Lilly partners with Nvidia on AI supercomputer to speed up drug development
PositiveFinancial Markets

Lilly has teamed up with Nvidia to create an AI supercomputer aimed at accelerating drug development. This partnership is significant as it harnesses cutting-edge technology to streamline the research process, potentially leading to faster delivery of new treatments. By leveraging AI, Lilly hopes to enhance its capabilities in discovering and developing innovative therapies, which could ultimately benefit patients and the healthcare industry.
— Curated by the World Pulse Now AI Editorial System









